Regulatory Compliance Tool Identification

We identify, evaluate, and validate the Tier 1 and Tier 2 support tools that produce defensible evidence against ISO 13485, 21 CFR Part 11, 21 CFR Part 820 (QMSR), and IEC 62304: so your auditors find documentation, not gaps.

Overview

Choosing a help-desk system or monitoring stack for a regulated MedTech product is not a procurement decision. It is a regulatory decision. Every ticket, signature, and configuration change becomes part of the device's lifecycle record. Picking the wrong tools forces costly retrofits when the FDA, BSI, or a Notified Body comes knocking.

Qscription's tool identification engagement produces a short list of validated tools mapped clause-by-clause to the regulations that apply to your device class, your geography, and your software safety classification.

Regulatory Coverage

ISO 13485

Quality management system controls. We confirm tools support clause 4.2.4 document control, clause 7.5.6 process validation, and clause 8.2.1 feedback loops with traceability into CAPA.

21 CFR Part 11

Electronic records and electronic signatures. We verify audit trail immutability, signature manifestation, and access controls that hold up during a Form 483 response.

21 CFR Part 820 (QMSR)

FDA's new Quality Management System Regulation harmonized with ISO 13485. We map tool functionality against the February 2026 effective date requirements and the new combination product clarifications.

IEC 62304

Software lifecycle for medical device software, Class A through C. We confirm change control, problem resolution, and configuration management evidence flows into the SOUP and risk records.

Our Process

  1. 1

    Scoping & classification

    We catalog your device classification, software safety class (IEC 62304 A/B/C), target markets, and existing QMS. Outcome: a one-page regulatory scope memo signed off by your QA lead.

  2. 2

    Vendor landscape & gap analysis

    Long-list of T1/T2 platforms (ITSM, monitoring, log management, knowledge base, e-signature). We score each against your regulatory scope and shortlist 2-3 candidates.

  3. 3

    Vendor audits & evidence requests

    We run vendor calls, request SOC 2 reports, Part 11 self-assessments, and validation packages. Tools that cannot produce evidence are eliminated.

  4. 4

    Validation package

    URS, FS, IQ/OQ/PQ protocols, traceability matrix, and a rationale memo. Drop into your DHF.

  5. 5

    Implementation handoff

    We brief your IT and QA teams, configure access controls, and stay on retainer through your first internal audit.

Frequently Asked Questions

Do you replace our QMS or integrate with it?

We integrate. Tool selection produces evidence that maps directly into your existing DHF, DMR, and risk files: Greenlight Guru, MasterControl, Veeva Vault QMS, or homegrown.

Which regulations does this cover?

ISO 13485, 21 CFR Part 11, 21 CFR Part 820 (QMSR), and IEC 62304. We cross-reference EU MDR Annex I where products are dual-market and ISO 14971 for risk traceability.

How long does an engagement take?

A typical assessment for one product line runs 4-6 weeks: 1 week scoping, 2-3 weeks vendor analysis & gap mapping, 1-2 weeks validation evidence package.

Do you produce audit-ready evidence?

Yes. Every deliverable is written to withstand FDA, BSI, and TÜV audits: traceability matrices, validation protocols, and rationale memos with signed-off review history.

What if our chosen vendor is not Part 11 compliant out of the box?

We document the gap, design compensating controls (procedural or technical), and validate the combined system. Many compliant deployments rely on configuration plus SOP, not vendor certification alone.

Ready to defend your toolchain?

Tell us your device, your markets, and your audit horizon. We'll come back with a fixed-scope proposal within 5 business days.

Start a Conversation